Amarin
Manufacturing · Connecticut, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
12 Roosevelt Ave Ste 3, Mystic, Connecti...Phone Number
+353 16699020Website
www.amarincorp.comRevenue
$216.8 MillionStock Symbol
AMRNIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Amarin
Founded in 1991, Amarin Corporation is a pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health. The company headquarters is located in Dublin, Ireland.Explore more
Amarin Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amarin your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Amarin is spiking on competitors!
Click to see if Amarin had a recent Job posting/layoffs
Amarin, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Amarin has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Amarin
Earning: See what the market has to say on Amarin recently announced quarterly report
Funding: Get notified immidiatlly once Amarin has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Amarin launches new products
Recommended Actions
Reach out to Masked Content who joined Amarin as Masked Content
Find 2 more new buyers
Compare Similar Companies to Amarin
Compare insights from companies similar to Amarin, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Amarin is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amarin is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amarin.
Amarin financials insights
Gather financial insights about Amarin, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Multiple Rounds
$130.6M
2012
Debt
$150M
Corporate Investment
$100M
2015
Share Placement
$52.8M
Debt
$31.3M
2018
Stock Offering
$200M
2019
Stock Offering
$400M
Amarin Tech Stack
A closer look at the technologies used by Amarin
Most Recent Scoops
Person-Based
Person-Based
Promotion
Executive Move
Executive Moves, Promotion
Award
Award, Employee Engagement, Employee Relations, Employee Retention, Company Culture & Policy, Diversity & Inclusion, HR Operations, Organizational Development, Talent Management
Person-Based
Amarin News & Media
Amarin Reports Second-Quarter Results as Partnered International Strategy Gains Momentum
Strong international demand growth and lower operating expenses supported improved profitability metrics as Amarin reaffirmed confidence in its global commercialization strategy. Key Investor TakeawaysAmarin (NASDAQ:AMRN) reported strong international in-market demand growth, with partner network sales increasing 59% year over year despite lower reported revenue.Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash FlowAmarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
DUBLIN, Ireland and BRIDGEWATER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced that it will report second quarter 2026 financial results and conduct a conference call on Wednesday, July 29, 2026. The Company will issue a press release detailing its second quarter 2026 financial results in the pre-market hours, followed by a conference call with senior management at 8:00 a.m.Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
Clinically Validated, Increasingly Prescribed, Widely Reimbursed, and Affordable, VASCEPA Expected to Benefit from Increased Attention to Patients with Severely Elevated Triglycerides Clinically Validated, Increasingly Prescribed, Widely Reimbursed, and Affordable, VASCEPA Expected to Benefit from Increased Attention to Patients with Severely Elevated Triglycerides
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amarin
Sign Up For FreeTo access detailed company insights
Founded in 1991, Amarin Corporation is a pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health. The company headquarters is located in Dublin, Ireland.... Read More
